Sciatica Market Research Report- Forecast till 2027

Sciatica Market Information: By Type (L4, L5, S1), Drug Treatment (Anesthetic, Pain Killer, Muscle Relaxant, Antidepressant, Steroid), Non-Drug Treatment (Physiotherapy, Acupuncture, Stimulation Device), End User (Hospital) - Forecast Till 2027

ID: MRFR/Pharma/3341-HCR | | Region: Global | 110 pages

Market Synopsis of Sciatica Market


Market Scenario

Sciatica is characterized by pain going down the leg from the lower back due to irritation of the lumbar or sacral nerves. Sciatica is triggered by activities like heavy lifting and jerky movements. However the condition can also develop gradually. Typically, sciatica symptoms occur on one side of the body although in some cases the pain can be on both sides. The other symptoms of sciatica are weakness or numbness in the affected leg, burning or tingling down the affected leg, and constant pain on one side of the rear. The causes of sciatica are spondylolisthesis, muscle spasm in the back or buttock, spinal stenosis, piriformis syndrome, pelvic tumours, pregnancy and others. However, spinal disc herniation is the primary cause of sciatica in about 90% of the cases. Other uncommon causes are lumbar degenerative disc disease, osteophytes and arthritis of the spine.

Sciatica generally resolves on its own in about 90% of the cases. However it can result in severe pain which may need surgical intervention. Surgery may be required if complications occur such as bowel or bladder problems. Sciatica affects 40% of people at some point in their life time. Sciatica is most common during people's 40s and 50s, and men are more frequently affected than women.

The market drivers for global sciatica market are rise in demand due to growing population, increasing screening, rising cases of geriatrics, rising safety and success of drug treatment, the extricating nature of the pain and others. The market restraints are the complications of surgery such as risk of bleeding, infections, pain, high cost of sciatica treatment, and others.

The global sciatica market is expected to reach USD 18.9 billion by 2023, and the market is projected to grow at a CAGR of ~ 8.0 % during the forecast period 2017-2023.

Figure 1          Global Sciatica Market by Drug Treatment, 2016 (%) Global Sciatica Market


Segments


The global sciatica market has been segmented on the basis of types, drug treatment, devices and end user.


Based on the types, the sciatica market has been segmented as L4 nerve root sciatica, L5 nerve root sciatica, S1 nerve root sciatica and others.


Based on the drugs, the market has been segmented as anesthetics, pain killers, muscle relaxants, antidepressants, steroids and others.


Based on the non-drug treatment, the market has been segmented as physiotherapy, acupuncture, stimulation devices, surgery and others.


Based on the end user, the market has been segmented as hospitals and clinics, research and academics and others.


Regional Analysis


The Americas accounts for a significant sciatica market share owing to high expenditure on the healthcare especially of the U.S. and Canada. Additionally, greater number of orthopedic procedures due to greater healthcare penetration in the U.S. and Canada drives the sciatica market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of surgical procedures especially the sciatica treatment in the returns of hospitals favors the market. A large number of medical devices companies in the U.S. is also a cause for the faster development of sciatica market in the US.


Europe is the second largest market in the world due to the growing medical devices industry and healthcare penetration. The European market growth is led by countries such as Germany and France. Germany is expected to be the fastest growing market over the assessment period due to its large medical devices industry.


Asia Pacific region is expected to grow rapidly where China and India are likely to lead the market due to faster growing healthcare sector and larger unmet needs over the forecast period. The South East Asian countries such as China, India, and Malaysia are projected to contribute highly to the market growth. The growing penetration of healthcare industry in the Asia Pacific region is expected to drive the future sciatica market in the region.


Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. Other Middle Eastern nations to watch out for are Kuwait, Jordan, Egypt and Iran. The African region is expected to witness a poor growth owing to poor economic and political conditions, and poor healthcare development. Other regions are expected to be laggards due to poor social development and tribal identities such as sub Saharan Africa.


Key Players in the Global Sciatica Market


Some of the key players profiled in the report are Endo Pharmaceuticals, AstraZeneca, Novartis AG, Teva Pharmaceutical Industries, Neurotech, Nidd Valley Medical, Omega Laser Systems Ltd., Omron Healthcare, Inc., Sanofi and others.


Research Methodology Sciatica Market


Sources: Mayo Clinic, Healthline Media, MRFR Analysis


Intended Audience



  • Global Sciatica manufacturers & suppliers

  • Research and development (R&D) companies

  • Hospitals and clinics

  • Academic institutes and universities


 



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :


Sciatica market size is projected to expand at 8% CAGR from 2017 to 2023.

Sciatica market valuation can touch USD 18.9 billion by 2023.

Sciatica market is driven by the large elderly populace and intense screening procedures for detection of nerve pain.

High costs of sciatica treatment and adverse effects of its drugs can stunt the global sciatica market growth.

Neurotech, Novartis AG, AstraZeneca, Sanofi, Endo Pharmaceuticals, Omega Laser Systems Ltd., Teva Pharmaceutical Industries, Omron Healthcare, Inc., and Nidd Valley Medical are key players of the global sciatica market.

Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Sciatica Market, by Type

6.1 Introduction

6.2 L4 Nerve Root Sciatica

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 L5 Nerve Root Sciatica

6.3.1 Market Estimates & Forecast, 2020-2027

6.4 S1 Nerve Root Sciatica

6.4.1 Market Estimates & Forecast, 2020-2027

6.5 Others

6.5.1 Market Estimates & Forecast, 2020-2027

7. Global Sciatica Market, by Drug Treatment

7.1 Introduction

7.2 Anesthetics

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Pain Killers

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Muscle Relaxants

7.4.1 Market Estimates & Forecast, 2020-2027

7.5 Antidepressants

7.5.1 Market Estimates & Forecast, 2020-2027

7.6 Steroids

7.6.1 Market Estimates & Forecast, 2020-2027

7.7 Others

7.7.1 Market Estimates & Forecast, 2020-2027

8. Global Sciatica Market, by Non-drug Treatment

8.1 Introduction

8.2 Physiotherapy

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Acupuncture

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Stimulation Devices

8.4.1 Market Estimates & Forecast, 2020-2027

8.5 Surgery

8.5.1 Market Estimates & Forecast, 2020-2027

8.6 Others

8.6.1 Market Estimates & Forecast, 2020-2027

9. Global Sciatica Market, by End User

9.1 Introduction

9.2 Hospitals and Clinics

9.2.1 Market Estimates & Forecast, 2020-2027

9.3 Research and Academics

9.3.1 Market Estimates & Forecast, 2020-2027

9.4 Others

9.4.1 Market Estimates & Forecast, 2020-2027

10. Global Sciatica Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 U.K

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profiles

12.1 Endo Pharmaceuticals

12.1.1 Overview

12.1.2 Product Overview

12.1.3 Financials

12.2 AstraZeneca

12.2.1 Overview

12.2.2 Product Overview

12.2.3 Financials

12.2.4 Key Developments

12.3 Novartis AG

12.3.1 Overview

12.3.2 Product Overview

12.3.3 Financials

12.3.4 Key Development

12.4 Teva Pharmaceutical Industries

12.4.1 Overview

12.4.2 Product Overview

12.4.3 Financials

12.4.4 Key Development

12.5 Neurotech

12.5.1 Overview

12.5.2 Product Overview

12.5.3 Financials

12.5.4 Key Development

12.6 Nidd Valley Medical

12.6.1 Overview

12.6.2 Product Overview

12.6.3 Financials

12.6.4 Key Development

12.7 Omega Laser Systems Ltd.

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Development

12.8 Omron Healthcare, Inc.

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Development

12.9 Others

13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Sciatica Industry

14 Appendix

List of Tables

TABLE 1 GLOBAL SCIATICA MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 2 L4 NERVE ROOT SCIATICA FOR SCIATICA MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 3 L5 NERVE ROOT SCIATICA FOR SCIATICA MARKET, BY REGION 2020-2027 (USD

MILLION)

TABLE 4 S1 NERVE ROOT SCIATICA FOR SCIATICA MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 5 OTHER FOR SCIATICA MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 6 GLOBAL SCIATICA MARKET, BY DRUG TREATMENT, 2020-2027 (USD MILLION)

TABLE 7 ANESTHETICS FOR SCIATICA MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 8 PAIN KILLERS FOR SCIATICA MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 9 MUSCLE RELAXANTS FOR SCIATICA MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 10 ANTIDEPRESSANTS FOR SCIATICA MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 11 STEROIDS FOR SCIATICA MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 12 OTHERS FOR SCIATICA MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 13 GLOBAL SCIATICA MARKET, BY NON-DRUG TREATMENT, 2020-2027 (USD MILLION)

TABLE 14 PHYSIOTHERAPY FOR SCIATICA MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 15 ACUPUNCTURE FOR SCIATICA MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 16 STIMULATION DEVICES FOR SCIATICA MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 17 SURGERY FOR SCIATICA MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 18 OTHERS FOR SCIATICA MARKET, BY REGION 2020-2027 (USD MILLION)

TABLE 19 GLOBAL SCIATICA MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 20 NORTH AMERICA SCIATICA MARKET, BY COUNTRY 2020-2027 (USD MILLION)

TABLE 21 NORTH AMERICA SCIATICA MARKET, BY TYPE 2020-2027 (USD MILLION)

TABLE 22 NORTH AMERICA SCIATICA MARKET, BY DRUG TREATMENT 2020-2027 (USD MILLION)

TABLE 23 NORTH AMERICA SCIATICA MARKET, BY NON-DRUG TREATMENT 2020-2027 (USD MILLION)

TABLE 24 NORTH AMERICA SCIATICA MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 25 NORTH AMERICA SCIATICA MARKET BY REGION 2020-2027 (USD MILLION)

TABLE 26 EUROPE SCIATICA MARKET, BY COUNTRY 2020-2027 (USD MILLION)

TABLE 27 EUROPE SCIATICA MARKET, BY TYPE 2020-2027 (USD MILLION)

TABLE 28 EUROPE SCIATICA MARKET, BY DRUG TREATMENT 2020-2027 (USD MILLION)

TABLE 29 EUROPE SCIATICA MARKET, BY NON-DRUG TREATMENT 2020-2027 (USD MILLION)

TABLE 30 EUROPE SCIATICA MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 31 EUROPE SCIATICA MARKET BY REGION 2020-2027 (USD MILLION)

TABLE 32 ASIA PACIFIC SCIATICA MARKET, BY COUNTRY 2020-2027 (USD MILLION)

TABLE 33 ASIA PACIFIC SCIATICA MARKET, BY TYPE 2020-2027 (USD MILLION)

TABLE 34 ASIA PACIFIC SCIATICA MARKET, BY DRUG TREATMENT 2020-2027 (USD MILLION)

TABLE 35 ASIA PACIFIC SCIATICA MARKET, BY NON-DRUG TREATMENT 2020-2027 (USD MILLION)

TABLE 36 ASIA PACIFIC SCIATICA MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 37 ASIA PACIFIC SCIATICA MARKET BY REGION 2020-2027 (USD MILLION

TABLE 38 MIDDLE EAST & AFRICA SCIATICA MARKET, BY COUNTRY 2020-2027 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA SCIATICA MARKET, BY TYPE 2020-2027 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA SCIATICA MARKET, BY DRUG TREATMENT 2020-2027 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA SCIATICA MARKET, BY NON-DRUG TREATMENT 2020-2027 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA SCIATICA MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA SCIATICA MARKET BY REGION 2020-2027 (USD MILLION

List of Figures

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET DYNAMICS FOR GLOBAL SCIATICA MARKET

FIGURE 3 GLOBAL SCIATICA MAKRET, BY SEGMENT, 2020

FIGURE 4 GLOBAL SCIATICA SUCCESS MARKET, BY REGION

FIGURE 5 GLOBAL SCIATICA MARKET SHARE, BY TYPE 2020

FIGURE 6 GLOBAL SCIATICA MARKET SHARE, BY DRUG TREATMENT 2020

FIGURE 7 GLOBAL SCIATICA MARKET SHARE, BY NON-DRUG TREATMENT 2020

FIGURE 8 GLOBAL SCIATICA MARKET SHARE, BY END USER, 2020

FIGURE 9 GLOBAL SCIATICA MARKET SHARE, 2020

FIGURE 10 GLOBAL SCIATICA MARKET SHARE, BY REGION, 2020

FIGURE 11 NORTH AMERICA SCIATICA MARKET SHARE, BY COUNTRY, 2020

FIGURE 12 EUROPE SCIATICA MARKET SHARE, BY COUNTRY, 2020

FIGURE 13 ASIA PACIFIC SCIATICA MARKET SHARE, BY COUNTRY, 2020

FIGURE 14 MIDDLE EAST & AFRICA SCIATICA MARKET, BY REGION, 2020

FIGURE 15 GLOBAL SCIATICA MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 16 ENDO PHARMACEUTICALS: KEY FINANCIALS

FIGURE 17 ENDO PHARMACEUTICALS: SEGMENTAL REVENUE

FIGURE 18 ENDO PHARMACEUTICALS: GEOGRAPHICAL REVENUE

FIGURE 19 ASTRAZENECA: KEY FINANCIALS

FIGURE 20 ASTRAZENECA SEGMENTAL REVENUE

FIGURE 21 ASTRAZENECA: GEOGRAPHICAL REVENUE

FIGURE 22 OMRON HEALTHCARE, INC: KEY FINANCIALS

FIGURE 23 OMRON HEALTHCARE, INC: SEGMENTAL REVENUE

FIGURE 24 OMRON HEALTHCARE, INC: GEOGRAPHICAL REVENUE

FIGURE 25 NIDD VALLEY MEDICAL: KEY FINANCIALS

FIGURE 26 NIDD VALLEY MEDICAL: SEGMENTAL REVENUE

FIGURE 27 NIDD VALLEY MEDICAL: GEOGRAPHICAL REVENUE

FIGURE 28 OMEGA LASER SYSTEMS LTD: FINANCIAL REVENUE

FIGURE 29 OMEGA LASER SYSTEMS LTD: SEGMENTAL REVENUE

FIGURE 30 OMEGA LASER SYSTEMS LTD: GEOGRPAHICAL REVENUE